Cargando…

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic

We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quickly identify people with high risk of COVID-19 infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonavita, Simona, Tedeschi, Gioacchino, Atreja, Ashish, Lavorgna, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162735/ https://www.ncbi.nlm.nih.gov/pubmed/32303856 http://dx.doi.org/10.1007/s10072-020-04391-9

Ejemplares similares

Dementia care and COVID-19 pandemic: a necessary digital revolution
por: Cuffaro, Luca, et al.
Publicado: (2020)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

Stroke and digital technology: a wake-up call from COVID-19 pandemic
por: Iodice, Francesco, et al.
Publicado: (2021)

Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
por: Ricciardi, Dario, et al.
Publicado: (2021)

Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail
por: Bombaci, Alessandro, et al.
Publicado: (2020)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Social Media and Multiple Sclerosis in the Posttruth Age
por: Lavorgna, Luigi, et al.
Publicado: (2017)

The Role of Wearable Devices in Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2018)

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

The future of neurology after the COVID-19 pandemic according to neurology residents
por: Ercoli, Tommaso, et al.
Publicado: (2022)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Disability, Disablism, and COVID-19 Pandemic Triage
por: Scully, Jackie Leach
Publicado: (2020)

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
por: Affinito, Giuseppina, et al.
Publicado: (2023)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
por: Kuzu Kumcu, Müge, et al.
Publicado: (2022)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
por: Giordano, Antonino, et al.
Publicado: (2021)

Triaging ethical issues in the coronavirus pandemic: how to prioritize bioethics research during public health emergencies
por: Shaw, David
Publicado: (2021)

Recommendations on COVID‐19 triage: international comparison and ethical analysis
por: Jöbges, Susanne, et al.
Publicado: (2020)

Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters
por: Arighi, Andrea, et al.
Publicado: (2021)

COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
por: Sadeghmousavi, Shaghayegh, et al.
Publicado: (2020)

Telemedicine and the challenge of epilepsy management at the time of COVID-19 pandemic()
por: Brigo, Francesco, et al.
Publicado: (2020)

COVID-19 impact on neurology training program in Italy
por: Di Lorenzo, Francesco, et al.
Publicado: (2021)

Effects of quarantine applied during the COVID-19 pandemic on mental health and quality of life in patients with multiple sclerosis and healthy controls
por: Koc, Emine Rabia, et al.
Publicado: (2022)

Impact of COVID-19 lockdown on progressive multiple sclerosis patients
por: Vercellino, Marco, et al.
Publicado: (2022)

An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)
por: Ferrarese, Carlo, et al.
Publicado: (2020)

Clinical Triaging in Cough Clinic Alleviates COVID-19 Overload in Emergency Department in India
por: Nayan, Neelabh, et al.
Publicado: (2021)

Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
por: Habek, Mario
Publicado: (2021)

Family Planning Decision Making in People With Multiple Sclerosis
por: Bonavita, Simona, et al.
Publicado: (2021)

What Triage Issues Reveal: Ethics in the COVID-19 Pandemic in Italy and France
por: Orfali, Kristina
Publicado: (2020)

Neurology and the COVID-19 emergency
por: Berardelli, Alfredo, et al.
Publicado: (2020)

Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
por: Shaygannejad, Vahid, et al.
Publicado: (2021)

Care for Older People with Dementia During COVID-19 Pandemic
por: Emmerton, Demelza, et al.
Publicado: (2021)

Morphostructural MRI Abnormalities Related to Neuropsychiatric Disorders Associated to Multiple Sclerosis
por: Bonavita, Simona, et al.
Publicado: (2013)

Vaccination status and intensive care unit triage: Is it fair to give unvaccinated Covid‐19 patients equal priority?
por: Shaw, David
Publicado: (2022)

Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020)

Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)
por: Dubbioso, Raffaele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oeplvhk30st1okr3pc8bmj6tqq